Rankings
▼
Calendar
DFTX Q4 2016 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DFTX
Definium Therapeutics, Inc.
$2B
Q4 2016 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$314,199
Net Income
-$318,489
EPS (Diluted)
$-2.05
Cash Flow
Operating Cash Flow
-$155,506
Free Cash Flow
-$492,190
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$778,782
Total Liabilities
$22,853
Stockholders' Equity
$755,928
Cash & Equivalents
$29,543
← FY 2016
All Quarters
Q1 2017 →
